Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
HealthCap is a European venture capital firm founded in 1996 and based in Stockholm, Sweden. The firm has raised nine funds and manages assets totaling EUR 1.2 billion. It has financed over 130 portfolio companies, leading to more than 35 approved pharmaceutical products and 47 initial public offerings (IPOs).
HealthCap invests in companies developing targeted therapies for rare diseases, cancers, and genetic disorders. Their strategy emphasizes emerging therapeutics that can significantly improve patient outcomes, particularly in precision medicine. Investment stages include seed, Series A, Series B, and growth equity.
Notable companies in HealthCap's portfolio include Actelion Holding Ltd, a leader in pulmonary arterial hypertension; Adcendo ApS, focused on antibody-drug conjugates for cancer; Aerogen Inc, known for pulmonary drug delivery products; Affibody AB, specializing in biopharmaceuticals; and Alba Therapeutics Corp, which develops therapeutics for inflammatory diseases.
Email your pitch deck to carl.kilander@healthcap.eu for consideration.
HealthCap often leads investment rounds, particularly in early-stage companies that align with their focus on life sciences.
The firm typically participates in follow-on investments to support portfolio companies as they grow and reach critical milestones.
HealthCap manages assets totaling EUR 1.2 billion across its nine funds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.